To address these issues, we used fear conditioning and the elevated zero maze (EZM) to assess fear memory and anxiety-like behavior, immunofluorescence and electrophysiology to assess neuronal activity, and pharmacology and trans-genetic mouse lines to assess the role of CB1R and CB2R. The gene discussed is CNR1; the disease is Anxiety.